Form 4 for NVCR NovoCure Ltd
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001645113-22-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-05 | 2022-01-03 | NVCR | Burke William Patrick | CHRO | S - Sale+OE | $76.00 | -3,951 | 41.0K | -9% | -$300.3K |
| DM | 2022-01-05 | 2022-01-03 | NVCR | Burke William Patrick | CHRO | M - OptEx | $10.49 | +28.6K | 43.7K | +190% | +$300.0K |
| DM | 2022-01-05 | 2022-01-03 | NVCR | Burke William Patrick | CHRO | M - OptEx | $0.00 | -28.6K | 6,098 | -82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-01-03 | S | D | 399 | $76.03 | 50,870 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke. |
| 2 | Common | Ordinary Shares | 2022-01-03 | M | A | 1,402 | $21.60 | 51,269 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke. |
| 3 | Common | Ordinary Shares | 2022-01-03 | S | D | 919 | $76.09 | 49,867 | D | — | — | (F2) On January 3, 2022, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke, Mr. Burke sold 919 shares in multiple trades at prices ranging from $76.00 to $76.09. The price reported above reflects the weighted average sale price. Mr. Burke hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Ordinary Shares | 2022-01-03 | M | A | 9,750 | $7.15 | 50,786 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke. |
| 5 | Common | Ordinary Shares | 2022-01-03 | S | D | 2,633 | $75.96 | 41,036 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke. |
| 6 | Common | Ordinary Shares | 2022-01-03 | M | A | 17,452 | $11.46 | 43,669 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke. |
| 7 | Derivative | Options to Buy Ordinary Shares | 2022-01-03 | M | D | 17,452 | $0.00 | 0 | D | $11.46 · — to 2026-02-24 | 17,452 Ordinary Shares | (F3) Fully vested as of the date hereof. |
| 8 | Derivative | Options to Buy Ordinary Shares | 2022-01-03 | M | D | 9,750 | $0.00 | 0 | D | $7.15 · — to 2027-02-21 | 9,750 Ordinary Shares | (F3) Fully vested as of the date hereof. |
| 9 | Derivative | Options to Buy Ordinary Shares | 2022-01-03 | M | D | 1,402 | $0.00 | 6,098 | D | $21.60 · — to 2027-10-30 | 1,402 Ordinary Shares | (F3) Fully vested as of the date hereof. |